Haemophilia A
Haemophilia A is a genetic bleeding disorder caused by a deficiency in clotting factor VIII, leading to prolonged bleeding episodes. Patients may experience spontaneous bleeding or excessive bleeding after injuries or surgeries.
Haemophilia A: Inno8 Medication Study
We are researching how different doses of the medication Inno8 work in people with haemophilia A. This study aims to understand its effects on the body.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Medizinische Universitaet Innsbruck
Univ.-Klinik für Innere Medizin V, Hämatologie und Onkologie
Innsbruck, Austria
Medical University Of Vienna
Univ.-Klinik für Innere Medizin I, Klinische Abteilung für Hämatologie und Hämostaseologie
Vienna, Austria
Vivantes Netzwerk fuer Gesundheit GmbH
Vivantes Berlin-Friedrichshain, Innere Medizin VI
Berlin, Germany
Sponsor: Novo Nordisk A/S
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.